2018 Speakers

Speakers

Peter Atadja
Executive Director & Head, Oncology Drug Discovery
CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
Hua Bai
Director, Clinical Pharmacology Research Center
PEKING UNION MEDICAL COLLEGE HOSPITAL
Ping-Chung Chang
Head, Biostatistics & Programming Operation Asia
PPD
Fiona Chen
Senior Director of the Bioanalysis Department
UNITED-POWER PHARMA
Howard Chen
Principal – Management Consulting
IQVIA CONSULTING
Jianwen Chen
Vice President, Medical Development
JIANGSU HENGRUI MEDICINE
Minhui Chen
Medical Affairs Director, Taiwan
PPC
PJ Chen
VP, Head of Clinical & Medical Affairs Center & President
UNITED BIOPHARMA CHINA
Xiaoxiang Chen
Executive Vice President, Head of Clinical Development and Regulatory Science
HARBOUR BIOMED
Julie Cong
Associate Director of Biostatistics
BOEHRINGER-INGELHEIM
Luyan Dai
Head of Biostatistics and Data Sciences Asia
HARBOUR BIOMED
Yi Fang
Director, Phase I Clinical Trials Institute
PEKING UNIVERSITY PEOPLE’S HOSPITAL
Alex Forrest
Head of Life Science, COG
CHUBB
David Fuller
Senior Vice President Clinical Development
SYNEOS HEALTH
Robert Gallagher
Senior Principal, Drug Development
IQVIA
John Gong
Chief Executive Officer
3D MED
Maggie Gu
Vice President, Clinical Research & Operations
SHANGHAI JUNSHI BIOSCIENCES
Tong Guo
VP & Head of Sales, R&D Solutions
IQVIA
Tony Guo
Executive Director, Head of Biostatistic
BEIGENE
Yongjiang Hei
Chief Medical Officer, Oncology
ZAI LAB
Jennifer Hou
Director, Phase I Clinical Center
PKUCARE LUZHONG HOSPITAL
Xichun Hu
Professor and Director, Medical Oncology
SHANGHAI CANCER CENTER, FUDAN UNIVERSITY
Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS
Min Irwin
Chief Executive Officer
REISTONE BIOPHARMA
Helen Jiang
Senior Vice President & Chief Medical Officer
QINGFENG MEDICINE
Yue Kang
China Development Director
ABBVIE
Minnie Ke
Country Medical Head
SHIRE
Sanghee Kim
Managing Director, Korea
PPC
Shu Lam
Senior Consultant
IQVIA
Howe Li
Founder, Chairman & Chief Executive Officer
DELTAMED
Ning Li
Executive Director, Chief Executive Officer and General Manager
JUNSHI BIOSCIENCES
Xuening Li
Director of of Medical Institution Conducting Clinical Trials for Human Used Drug
HUASHAN HOSPITAL OF FUDAN UNIVERSITY
Yong Li
Chief Physician, Cardiology
HUASHAN HOSPITAL OF FUDAN UNIVERSITY
Zhihong Li
VP of International Regulatory Affairs
FOUNTAIN MEDICAL DEVELOPMENT
Kevin Lin
Chief Executive Officer
JSURE HEALTH
Cece Liu
Life Science Specialist, Underwriting Manager of Industry Practices
CHUBB APAC
Demi Liu
Clinical Project Director
ZAI LAB
Scott Liu
President & Chief Executive Officer
SHANGHAI HENLIUS BIOTECH
Tianshu Liu
Director, Oncology Medical
ZHONGSHAN HOSPITAL
Yi Liu
Chief Medical Officer
KECHOW PHARMA
Chris Lu
Chief Executive Officer
LAEKNA THERAPEUTICS
Paul Manley
Executive Director, Leading Scientist Oncology Research
NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH
Yimin Mao
Professor of Gastroenterology & Chief Executive Officer, State Institution for Drug Clinical Research
RENJI HOSPITAL
Brian Mi
President, Greater China
IQVIA
Bin Peng
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS
Luana Pesco Koplowitz
President & Chief Medical & Scientific Officer
DUCK FLATS PHARMA
Sanjeev Redkar
Chief Executive Officer
CBT PHARMA
Joan Shen
Head of Research and Development
I-MAB BIOPHARMA
Yang Shen
Professor, Department of Hematology
RUIJIN HOSPITAL
Xiaowei Shi
Executive Director, Clinical Operations, Asia-Pacific
BEIGENE
Michael Stibilj
Chief Executive Officer, PPC Group
PPC
John Wan
Member of Board, Senior Vice President
BETTA PHARMA
Gloria Wang
Chief Medical Officer
TASLY BIOPHARMA
Heidi Wang
Vice President, Head of Global Regulatory Sciences China & Hong Kong
BRISTOL-MYERS SQUIBB
Jerry Wang
Head of Global Biostatistics, Epidemiology, and Medical Writing, China
MERCK SERONO
Jin Wang
Senior Director, Clinical Development
BEIGENE
Jonathan Wang
Partner
ORBIMED
Lin Wang
Head of Takeda Development Center; Asia Vice President, Global Medical Science & Development Operation, R&D
TAKEDA
Susan Wang
Head of Biostatistics and Data Sciences Asia
BOEHRINGER-INGELHEIM
Tao Wang
Director, Head of Biostatistics and Programming
JIANGSU HENGRUI MEDICINE
Limin Wen
Head of Clinical Development
FOSUN KITE BIOTECHNOLOGY
Michael Winlo
Chief Executive Officer
LINEAR CLINICAL RESEARCH
Yan Wu
Vice President, Head of Clinical Operation and Immunology Development
HUTCHISON MEDIPHARMA
Jason Yang
Chief Medical Officer, Senior Vice President, Clinical Development
CSTONE PHARMACEUTICALS
Sophia Yang
Senior Director of Clinical Research Operations
JW THERAPEUTICS
Guoliang Yu
Global CEO & Venture Partner
APOLLOMICS PHARMACEUTICALS / ORBIMED ASIA
Helen Yu
Executive Director, Clinical Development
IONIS PHARMACEUTICALS
Yong Yue
Chief Medical Officer
LAEKNA THERAPEUTICS
Carrie Zhang
Chief Executive Officer
ECLINWISE
Dan Zhang
Executive Chairman
FOUNTAIN MEDICAL DEVELOPMENT
Fangning Zhang
Partner
MCKINSEY & COMPANY
Hesheng Zhang
Chief Executive Officer
HEMAY PHARMACEUTICALS
Jing Zhang
Director, Phase I Clinical Trial Unit;Executive Deputy Director, Clinical Trials Institute
HUASHAN HOSPITAL
Lianshan Zhang
Senior Vice President and Global R&D President
JIANGSU HENGRUI MEDICINE
Mark Zhang
Partner
KING & WOOD MALLESONS
Xiaolin Zhang
Chief Executive Officer
DIZAL PHARMA
Bitao Zhao
Chief Operation Officer
ESTART MEDICAL
Sean Zhao
Head of US Patient Safety Surveillance, US Medical Affairs
ASTRAZENECA
Shirley Zhao
General Manager & President, China
BRISTOL-MYERS SQUIBB
Aileen Zhu
Senior Principal Biostatistician
CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
Zhenping Zhu
Chief Scientific Officer & President of R&D
3SBIO
Jason Zhu, MD
Chief Executive Officer, China
PPC Group
Jessie Zou
Chief Medical Officer
JIANGSU HENGRUI MEDICINE